Literature DB >> 3500418

Specificity of peptide presentation by a set of hybrid mouse class I MHC molecules.

J L Maryanski1, J P Abastado, P Kourilsky.   

Abstract

The class I molecules of the major histocompatibility complex (H-2 in mouse, HLA in man) are membrane proteins composed of a polymorphic heavy chain associated with beta-2-microglobulin. Recent studies suggest that class I molecules present peptides derived from processed antigens to the receptor of cytolytic T cells. In particular, in the H-2d haplotype, synthetic HLA peptides can be recognized on Kd-bearing target cells by Kd-restricted cytolytic T cells specific for HLA. Here we analyse the specificity of presentation of two HLA peptides by a set of chimaeric Kd/Dd molecules to four different cytolytic T-cell clones. We identify two distinct regions within the second external (alpha 2) domain of Kd that contribute to its specificity as a restriction element. Our results indicate that the binding of an immunogenic peptide by a class I molecule is not always sufficient for its recognition by the T-cell antigen receptor. This suggests that the major histocompatibility complex restriction element either interacts with the T-cell antigen receptor or induces the recognized conformation of the peptide.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500418     DOI: 10.1038/330660a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  3 in total

1.  A novel downstream regulatory element of the mouse H-2Kb class I major histocompatibility gene.

Authors:  J Králová; P Jansa; J Forejt
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

2.  Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.

Authors:  W Chen; S Khilko; J Fecondo; D H Margulies; J McCluskey
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

3.  Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.

Authors:  K T Hogan; N Shimojo; S F Walk; V H Engelhard; W L Maloy; J E Coligan; W E Biddison
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.